152 related articles for article (PubMed ID: 1207938)
21. [Drug modification of meteorism prior to radiography in the abdominal region].
Dorner HH; Lössl HJ; Rottkay Pv; Gerlach H
Med Welt; 1978 Jun; 29(23):969-72. PubMed ID: 661544
[No Abstract] [Full Text] [Related]
22. [Treatment of diarrhea with an eubiotic with enzyme activity (Mexase)].
Nava M; Celestino S
Prensa Med Mex; 1968; 33(1):57-8. PubMed ID: 4252872
[No Abstract] [Full Text] [Related]
23. [Possible therapeutic uses of lactulose other than in porto-systemic encephalopathy].
Alvaro D; Angelico M; Attili AF
Minerva Dietol Gastroenterol; 1986; 32(1):67-72. PubMed ID: 3703321
[No Abstract] [Full Text] [Related]
24. [Value of Spasmenzyme in gastroenterology].
Chevrel B
Med Chir Dig; 1976; 5(1):63-6. PubMed ID: 796596
[No Abstract] [Full Text] [Related]
25. [Intestine and liver-protective therapy].
Kremer H
Z Allgemeinmed; 1974 Oct; 50(28):1252-5. PubMed ID: 4446643
[No Abstract] [Full Text] [Related]
26. [Clinical observations on a new combination of principles regulating disgestion].
De Liperi E; Brunori F; Coli R; Cartoni F
Clin Ter; 1967 Mar; 40(6):565-72. PubMed ID: 5601195
[No Abstract] [Full Text] [Related]
27. [Activity of propaxoline in some spastic conditions].
Mainieri L; Franceschini MC
Minerva Med; 1969 Jan; 60(9):340-8. PubMed ID: 5766394
[No Abstract] [Full Text] [Related]
28. [Therapeutic results in non-specific intestinal disorders using Mexase].
Zawodsky L
Wien Med Wochenschr; 1969 Feb; 119(5):94-8. PubMed ID: 4239538
[No Abstract] [Full Text] [Related]
29. [Lactulose in the treatment of chronic portosystemic encephalopathies].
Seidlová V
Cesk Gastroenterol Vyz; 1974 Apr; 28(3):201-7. PubMed ID: 4447986
[No Abstract] [Full Text] [Related]
30. [Evaluation of a new antiflatulence and enzyme digestive drug].
Martin Abreu L
Prensa Med Mex; 1976; 41(3-4):122-4. PubMed ID: 785441
[No Abstract] [Full Text] [Related]
31. [Use of nerobol and mexase in combination with mineral water from Morshin health resort in chronic colitis].
Datsun TA
Vrach Delo; 1976 Jun; (6):78-82. PubMed ID: 135416
[No Abstract] [Full Text] [Related]
32. [Clinical experience with Paspertin in gastroenterology].
Kocián J; Kociánová J
Med Welt; 1975 Oct; 26(42):1939-42. PubMed ID: 1102837
[No Abstract] [Full Text] [Related]
33. [Treatment of digestive insufficiency. Experimental-therapeutic studies using Gillazym].
Wunderer A
Med Welt; 1973 Jan; 24(2):53-5. PubMed ID: 4803294
[No Abstract] [Full Text] [Related]
34. [Assessment of the efficacy of mebeverine in the complex therapy of chronic noncalculolis cholecystitis and biliary dysfunction].
Maev IV; Samsonov AA; Ul'iankina EV; Nikushkina IN; Salova LM; Shakh IuS
Eksp Klin Gastroenterol; 2007; (2):120-5. PubMed ID: 17539356
[No Abstract] [Full Text] [Related]
35. [Therapeutic use of a new drug association with antispastic action].
Castellana G
Minerva Med; 1970 Feb; 61(11):464-8. PubMed ID: 5417726
[No Abstract] [Full Text] [Related]
36. Tachykinin receptors as drug targets for motility disorders.
Hoogerwerf WA; Sarna SK
Dig Dis; 2006; 24(1-2):83-90. PubMed ID: 16699266
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of intestinal disorders with Mexase, a new enzyme-combination drug].
André W
Munch Med Wochenschr; 1967 Nov; 109(46):2429-33. PubMed ID: 4232723
[No Abstract] [Full Text] [Related]
38. Short term effect of lactulose therapy in patients with chronic renal failure.
Miura M; Nomoto Y; Sakai H
Tokai J Exp Clin Med; 1989 Mar; 14(1):29-34. PubMed ID: 2699952
[TBL] [Abstract][Full Text] [Related]
39. [Quality of results obtained in digestive pathology by acting upon motor, secretory and hormonal phenomena at the same time].
Darnis F; Streichenberger G
Therapeutique; 1973 Dec; 49(10):721-4. PubMed ID: 4600237
[No Abstract] [Full Text] [Related]
40. [Treatment of hepatic encephalopathy with lactulose].
Veljkov N; Kulenović S; Borovac N; Rezaković D
Med Arh; 1981; 35(5-6):267-9. PubMed ID: 7345270
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
